Literature DB >> 16053476

An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene.

H S Kim1, S-M Kim, S-W Kang, S-C Jung, K-S Lee, T-S Kim, Y-C Choi.   

Abstract

We report a patient with familial amyloid polyneuropathy. Gene analysis revealed a heterozygous Glu54Gly substitution (A-to-G change) in the transthyretin gene. This is the first case of a Glu54Gly substitution that was devoid of a Gly6Ser substitution. Compared with the previously reported case with compound heterozygotes of Glu54Gly and Gly6Ser, the age of onset in our case is much younger and another characteristic findings were the amyloid vasculopathy and the multiple organ involvement. A Glu54Gly mutation is amyloidogenic by itself and a Gly6Ser mutation may offer some protection from the Glu54Gly mutant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16053476     DOI: 10.1111/j.1468-1331.2005.01005.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  3 in total

1.  Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.

Authors:  T M O'Hearn; A Fawzi; S He; N A Rao; J I Lim
Journal:  Br J Ophthalmol       Date:  2007-05-23       Impact factor: 4.638

2.  A woman with a rare p.Glu74Gly transthyretin mutation presenting exclusively with a rapidly progressive neuropathy: a case report.

Authors:  Anne Schänzer; Christoph Kimmich; Christoph Röcken; Thomas Haverkamp; Isabell Weidner; Till Acker; Heidrun H Krämer
Journal:  J Med Case Rep       Date:  2014-12-04

3.  Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis.

Authors:  Kyomin Choi; Jin Myoung Seok; Byoung Joon Kim; Young Cheol Choi; Ha Young Shin; Il Nam Sunwoo; Dae Seong Kim; Jung Joon Sung; Ga Yeon Lee; Eun Seok Jeon; Nam Hee Kim; Ju Hong Min; Jeeyoung Oh
Journal:  J Clin Neurol       Date:  2018-10       Impact factor: 3.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.